Treatment of Antibody-Mediated Renal Allograft Rejection with Bortezomib or Rituximab

被引：0
|
作者：
Waiser, Johannes [1 ]
Schuetz, Manuela [1 ]
Liefeldt, Lutz [1 ]
Schoenemann, Constanze [2 ]
Neumayer, Hans-H. [1 ]
Budde, Klemens [1 ]
机构：
[1] Charite, Dept Internal Med Nephrol, D-13353 Berlin, Germany
[2] Charite, HLA Lab, D-13353 Berlin, Germany
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2010年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：466 / 467
页数：2
相关论文
共 50 条
  • [1] Comparison between bortezomib and rituximab in the treatment of antibody-mediated renal allograft rejection
    Waiser, Johannes
    Budde, Klemens
    Schuetz, Manuela
    Liefeldt, Lutz
    Rudolph, Birgit
    Schoenemann, Constanze
    Neumayer, Hans-H
    Lachmann, Nils
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (03) : 1246 - 1251
  • [2] BORTEZOMIB VERSUS RITUXIMAB IN THE TREATMENT OF ANTIBODY MEDIATED RENAL ALLOGRAFT REJECTION
    Lachmann, N.
    Schoenemann, C.
    Budde, K.
    Schuetz, M.
    Liefeldt, L.
    Rudolph, B.
    Neumayer, H. -H.
    Waiser, J.
    [J]. TRANSPLANT INTERNATIONAL, 2011, 24 : 21 - 21
  • [3] Comparison between bortezomib and rituximab in the treatment of antibody mediated renal allograft rejection
    Lachmann, N.
    Schoenemann, C.
    Budde, K.
    Schuetz, M.
    Liefeldt, L.
    Rudolph, B.
    Neumayer, H. -H.
    Waiser, J.
    [J]. TISSUE ANTIGENS, 2011, 77 (05): : 388 - 388
  • [4] Rituximab and intravenous immunoglobulin treatment for chronic antibody-mediated renal allograft rejection
    Fehr, T.
    Gaspert, A.
    Ruesi-Elsener, B.
    Weber, M.
    Fischer, A.
    Wuethrich, R. P.
    [J]. SWISS MEDICAL WEEKLY, 2008, 138 (47-48) : 15S - 15S
  • [5] Rituximab in Combination With Bortezomib, Plasmapheresis, and High-Dose IVIG to Treat Antibody-Mediated Renal Allograft Rejection
    Waiser, Johannes
    Duerr, Michael
    Schoenemann, Constanze
    Rudolph, Birgit
    Wu, Kaiyin
    Halleck, Fabian
    Budde, Klemens
    Lachmann, Nils
    [J]. TRANSPLANTATION DIRECT, 2016, 2 (08): : E91
  • [6] Review of Bortezomib Treatment of Antibody-Mediated Rejection in Renal Transplantation
    Ejaz, Nicole S.
    Alloway, Rita R.
    Halleck, Fabian
    Duerr, Michael
    Budde, Klemens
    Woodle, E. Steve
    [J]. ANTIOXIDANTS & REDOX SIGNALING, 2014, 21 (17) : 2401 - 2418
  • [7] Treatment of Acute Antibody-Mediated Renal Allograft Rejection With Cyclophosphamide
    Waiser, Johannes
    Duerr, Michael
    Budde, Klemens
    Rudolph, Birgit
    Wu, Kaiyin
    Bachmann, Friederike
    Halleck, Fabian
    Schonemann, Constanze
    Lachmann, Nils
    [J]. TRANSPLANTATION, 2017, 101 (10) : 2545 - 2552
  • [8] Rituximab and Intravenous Immunoglobulin Treatment of Chronic Antibody-Mediated Kidney Allograft Rejection
    Fehr, Thomas
    Ruesi, Barbara
    Fischer, Andreas
    Hopfer, Helmut
    Wuethrich, Rudolf P.
    Gaspert, Ariana
    [J]. TRANSPLANTATION, 2009, 87 (12) : 1837 - 1841
  • [9] Bortezomib and antibody mediated rejection in renal allograft recipients
    Farrah, Tariq
    Phelan, Paul J.
    Battle, Richard
    Turner, David
    Henderson, Lorna
    [J]. TRANSPLANTATION, 2016, 100 (07) : S613 - S613
  • [10] Bortezomib for antibody-mediated rejection of renal transplant in youth
    Galea, Lauren
    Hewlett, Jennifer
    Savant, Jon
    Lopez, Sonya
    Amaral, Sandra
    Viteri, Bernarda
    [J]. PEDIATRIC TRANSPLANTATION, 2022, 26
12345